On 14 August 2024, the World Health Organization declared the epidemic a public health emergency of international concern (PHEIC). A month after the WHO’s announcement, the small Danish biotech firm, Bavarian Nordic, became the first in the world to receive approval for a monkeypox vaccine, JYNNEOS (known internationally as Imvamune or Imvanex), initially developed for smallpox but was rarely used.
https://www.activistpost.com/2024/09/mpox-project-bioshield-everyones-dark-winter.html
On 14 August 2024, the World Health Organization declared the epidemic a public health emergency of international concern (PHEIC). A month after the WHO’s announcement, the small Danish biotech firm, Bavarian Nordic, became the first in the world to receive approval for a monkeypox vaccine, JYNNEOS (known internationally as Imvamune or Imvanex), initially developed for smallpox but was rarely used. https://www.activistpost.com/2024/09/mpox-project-bioshield-everyones-dark-winter.html
WWW.ACTIVISTPOST.COM
Mpox, Project Bioshield: Everyone’s Dark Winter? - Activist Post
Project Bioshield was a ten-year program managed by Biomedical Advanced Research and Development Authority (BARDA), part HHS.
0 Comments 0 Shares 246 Views 0 Reviews
Sponsored
Sponsored